New Resources Available to Clinicians and Their Patients With Diabetes

The National Medical Association (NMA), the nation’s oldest and largest medical association representing over 50,000 African American physicians and their patients, has announced an initiative undertaken with Pfizer Inc. to raise awareness of painful diabetic peripheral neuropathy (DPN).

Diabetic nerve pain is a growing problem in the black American community where an estimated 1 in 5 black Americans has diabetes. Black Americans are also nearly three times as likely as non-Hispanic whites to have a lower-extremity amputation due to diabetes complications. To help address painful DPN with their clients, the NMA and Pfizer are making new DPN diagnosis and treatment resources available to NMA members. Read a news alert from the NMA here.

Related Content